• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Anatomy and Cell Biology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Anatomy and Cell Biology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

    Thumbnail
    View/ Open
    bjc201110a.PMC3048206.pdf (757.0Kb)

    Show full item record
    
    Author
    Boykin, Christi; Zhang, G.; Chen, Y-H; Zhang, R-W; Fan, X-E; Yang, W-M; Lu, Q.
    URI
    http://hdl.handle.net/10342/5298
    Date
    2011-03
    Citation:
    APA:
    Boykin, Christi, & Zhang, G., & Chen, Y-H, & Zhang, R-W, & Fan, X-E, & Yang, W-M, & Lu, Q.. (March 2011). Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. British Journal of Cancer, (104:5), p.781-789. Retrieved from http://hdl.handle.net/10342/5298

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Boykin, Christi, and Zhang, G., and Chen, Y-H, and Zhang, R-W, and Fan, X-E, and Yang, W-M, and Lu, Q.. "Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation". British Journal of Cancer. 104:5. (781-789.), March 2011. March 02, 2021. http://hdl.handle.net/10342/5298.
    Chicago:
    Boykin, Christi and Zhang, G. and Chen, Y-H and Zhang, R-W and Fan, X-E and Yang, W-M and Lu, Q., "Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation," British Journal of Cancer 104, no. 5 (March 2011), http://hdl.handle.net/10342/5298 (accessed March 02, 2021).
    AMA:
    Boykin, Christi, Zhang, G., Chen, Y-H, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q.. Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. British Journal of Cancer. March 2011; 104(5) 781-789. http://hdl.handle.net/10342/5298. Accessed March 02, 2021.
    Collections
    • Anatomy and Cell Biology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback